Takeda Pharmaceutical Co Ltd (TAK)
13.31
-0.08
(-0.60%)
USD |
NYSE |
May 16, 16:00
13.32
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Price to Book Value: 0.8692 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 0.8692 |
| May 15, 2024 | 0.8744 |
| May 14, 2024 | 0.8783 |
| May 13, 2024 | 0.8561 |
| May 10, 2024 | 0.8652 |
| May 09, 2024 | 0.8731 |
| May 08, 2024 | 0.8528 |
| May 07, 2024 | 0.8672 |
| May 06, 2024 | 0.8724 |
| May 03, 2024 | 0.8731 |
| May 02, 2024 | 0.8666 |
| May 01, 2024 | 0.8613 |
| April 30, 2024 | 0.8541 |
| April 29, 2024 | 0.86 |
| April 26, 2024 | 0.8509 |
| April 25, 2024 | 0.8535 |
| April 24, 2024 | 0.8639 |
| April 23, 2024 | 0.8737 |
| April 22, 2024 | 0.8724 |
| April 19, 2024 | 0.8646 |
| April 18, 2024 | 0.8594 |
| April 17, 2024 | 0.8587 |
| April 16, 2024 | 0.8639 |
| April 15, 2024 | 0.8607 |
| April 12, 2024 | 0.8731 |
| Date | Value |
|---|---|
| April 11, 2024 | 0.8868 |
| April 10, 2024 | 0.8861 |
| April 09, 2024 | 0.8914 |
| April 08, 2024 | 0.8927 |
| April 05, 2024 | 0.8894 |
| April 04, 2024 | 0.8803 |
| April 03, 2024 | 0.8835 |
| April 02, 2024 | 0.8848 |
| April 01, 2024 | 0.8927 |
| March 31, 2024 | |
| March 28, 2024 | 0.9117 |
| March 27, 2024 | 0.9314 |
| March 26, 2024 | 0.9445 |
| March 25, 2024 | 0.9287 |
| March 22, 2024 | 0.9458 |
| March 21, 2024 | 0.9425 |
| March 20, 2024 | 0.955 |
| March 19, 2024 | 0.9458 |
| March 18, 2024 | 0.9556 |
| March 15, 2024 | 0.9497 |
| March 14, 2024 | 0.9412 |
| March 13, 2024 | 0.9465 |
| March 12, 2024 | 0.9432 |
| March 11, 2024 | 0.9563 |
| March 08, 2024 | 0.9694 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.831
Minimum
Oct 19 2022
1.457
Maximum
Nov 19 2019
1.095
Average
1.070
Median
May 22 2023
Price to Book Value Benchmarks
| Astellas Pharma Inc | 1.628 |
| Nxera Pharma Co Ltd | 1.998 |
| PeptiDream Inc | 6.746 |
| Healios KK | 3.663 |
| AnGes Inc | 0.4409 |
Price to Book Value Related Metrics
| PE Ratio | 41.38 |
| PS Ratio | 1.425 |
| Price to Free Cash Flow | 25.78 |
| Price | 13.31 |
| Earnings Yield | 2.42% |
| Market Cap | 41.77B |
| Operating PE Ratio | 33.17 |
| Normalized PE Ratio | 41.38 |